• New Patient Forms
  • Patient Login
  • Pay My Bill
  • Request An Appointment
Pima Heart and Vascular
  • For Patients
    • Cardiac Care
    • Vascular Care
    • Outpatient Services
    • Our Providers
    • Locations
    • Resources
      • Cardiac Resources
      • Vascular Resources
      • Outpatient Resources
  • For Physicians
    • Our Providers
    • Make a Referral
    • Research Projects & Studies
    • Publications
    • Physician Training
  • Our Practice
    • About Us
    • Leadership
    • Accreditation & Awards
    • Testimonials
  • Contact Us
  • News

COVID-19 Announcement

Research Projects & Studies

  • For Physicians

    Make a Referral
    Research Projects & Studies
    Publications
    Physician Training

  • Investigational Products, Systems and Devices
    Pima Heart and Vascular physicians are committed to finding new and innovative treatments that will help improve the quality of life for people with cardiovascular and venous disease. Highly regarded as leaders in their field, they are invited as key speakers for medical conferences and continuing medical education meetings across the world.

    As new treatments, systems and devices are developed, several of the largest companies who develop these new technologies look to our physicians for testing and evaluation. Pima Heart and Vascular surgeons have played a role in some of the most exciting breakthroughs over the past several years.

    AMPLATZER PFO Occluder Post Approval Study (PFO PAS)
    The purpose of this single-arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval Setting.

    Sponsor: Abbott
    Principal Investigator: Dr. Waggoner
    Sub Investigators: Drs. Gheewala and Thomas

    Public Link

    Restore EF
    Aims to replicate real-world evidence and prior clinical investigations to demonstrate the long-term benefits of Protected PCI on LVEF and patient quality of life.

    Sponsor: ABIOMED
    Principal Investigator: Dr. Waggoner

    PROTECTED TAVR
    To demonstrate that use of the Sentinel® Cerebral Protection System significantly reduces the risk of peri-procedural stroke (≤72 hours) after transcatheter aortic valve replacement (TAVR).

    Principal Investigator: Dr. Waggoner
    Sub Investigators: Drs. Gheewala and Thomas

    Public Link 

    Assessing the Role of Pressure Recovery in Determining Elevated Transvalvular Gradients by Echocardiography Following TAVR for Native Aortic Stenosis and ViV Degenerated Bioprosthetic Valves: A Retrospective Study

    Multicenter collaboration led by Beaumont William Hospital
    Principal Investigator: Dr. Waggoner

    • For Patients
    • Locations
    • Our Providers
    • Cardiac Resources
    • Vascular Resources
    • Outpatient Resources
    • For Physicians
    • Make a Referral
    • Research Projects
    • Publications
    • Physician Training
    • Our Practice
    • About Us
    • Leadership
    • Accreditation & Awards

    520-838-3540

    Designed & Developed by
    Pinnacle Marketing Consulting
    • Terms & Conditions
    • Privacy Policy